Search
Close this search box.

Current Good Manufacturing Practices (CGMP) Compliance Issues for Gene Therapy Products

Organization:
United States Pharmacopeial Convention
NIIMBL Funded:
No
Type:
Professional Development / Training
Relevant Technologies:
Analytical Methods / Technologies
Delivery Modalities:
Online/E-Learning
Type of Enterprise:
Tier 1/Tier 2
Contact:
Location:
Middle Atlantic
Duration:
0-1 Week
Description:
Phase specific GMPS – Phase I Chain of Custody/Chain of Identity GMPs to ensure patient safety – Phase II and III – Phase 2 and 3 manufacturing will continue to be subject to parts 210 and 211. Visit website for full description